Our results suggest that the role of IL-6 in infection is complex and more extensive than just the induction of an acute phase immune response (62), consistent with the observed lack of an impact of IL-6 blockade in randomized clinical trials in patients with COVID-19 (63, 64). Here, IL6 is linked to infection.